[3H]CNQX

SynDRA canonical compound SYN1959325 — structure-anchored drug synonym record

Clinical phase	Phase 1
Primary target(s)	GRIA1 \| GRIA2 \| GRIA3 \| GRIA4
Mechanism of action	glutamate receptor antagonist

All known targets

GRIA1
GRIA2
GRIA3
GRIA4

Mechanisms of action (all sources)

GRIA1 ANTAGONIST
GRIA3 MODULATOR
GRIA4 MODULATOR
GRIA2 ANTAGONIST

Cross-references

PubChem CID: 3721046
ChEBI: 34468
TTD: D0E5UQ

Synonyms

6-Cyano-7-nitroquinoxaline-2,3-dione
CNQX
7-Nitro-2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carbonitrile
UNII-6OTE87SCCW
FG-9065
6OTE87SCCW
6-Cyano-2,3-dihydroxy-7-nitroquinoxaline
CHEBI:34468
1,4-dihydro-2,3-dihydroxy-7-nitro-6-quinoxalinecarbonitrile
7-nitro-2,3-dioxo-1,4-dihydroquinoxaline-6-carbonitrile
6-Quinoxalinecarbonitrile, 1,2,3,4-tetrahydro-7-nitro-2,3-dioxo-
ST50405216
2,3-dihydroxy-7-nitro-6-quinoxalinecarbonitrile
FG9065
AC1MWAKF
Tocris-0190
Biomol-NT_000200

Look up [3H]CNQX in the interactive SynDRA portal →